Delivery Order SPE2DR25D3012-SPE2DR26F4F6T
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,921.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $21,473.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 22, 2026, with completion scheduled for January 23, 2026. This competitive award, structured as a firm fixed-price delivery order with no set-aside designation, represents a task order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $37,240.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 14, 2026, with performance based in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $11,562.78. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, utilizing no set-aside designation and awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $94,228.99 and is scheduled for completion by August 12, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $30,717.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (quantity 90) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $11,977.20 to AmerisourceBergen Drug Corp for 90-count supplies of Jardiance 25 mg tablets, with completion scheduled for January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $121,701.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 12, 2026, with completion scheduled for January 13, 2026. This firm fixed-price, competitively awarded contract—which includes no set-aside designation—will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order valued at $35,987.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4F6TDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $117,091.18. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The contract is scheduled for ultimate completion by January 27, 2026, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Jardiance, an oral diabetes medication, falls within the company's extensive portfolio of brand-name and generic drugs that it regularly delivers to support Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $117.1k | 1/25/26 |